🎧 Available now!

Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.

Listen here: bit.ly/461LUWN

#LungCancerConsidered #ThoracicOncology

LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer | IASLC As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with two expert card ...

🎧 New #LungCancerConsidered episode

Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer

LCC in Georgian: WCLC 2025 Highlights | IASLC The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer resear ...

In this #LungCancerConsidered episode, Dr. Elene Mariamidze speaks with Dr. Salome Begijanashvili, Dr. Beka Shubitidze & Dr. Mariam Tchiabrishvili in Georgian about the most impactful #WCLC25 data and clinical updates.

Listen now: bit.ly/WCLC25Georgian #Georgia #Georgian

Interview with Dr. Bryant Lin: Teaching My Lung Cancer | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Dr. Bryant Lin, Clinical Professor of Medicine at Stanford University and co-founder ...

Every story shared during #LungCancerAwarenessMonth helps break stigma and build understanding.

In this #LungCancerConsidered episode, Dr. Bryant Lin shares his journey as both a doctor and patient with stage IV lung cancer.

Listen now: bit.ly/47ybmmI

New Lung Cancer Considered Episode in Mandarin - IASLC - OncoDaily New Lung Cancer Considered Episode in Mandarin - IASLC / cancer, Chunxia Su, IASLC, Lung Cancer Considered, Nan Bi, OncoDaily, Oncology, The International

IASLC - New Lung Cancer Considered Episode in Mandarin

@iaslc.bsky.social

oncodaily.com/voices/lung-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerConsidered #IASLC

Live From WCLC 2025: Monday Highlights | IASLC In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tin ...

What were the key highlights from #WCLC25 on Monday?

In this #LungCancerConsidered episode, @narjustflorezmd.bsky.social & @stephenvliu.bsky.social discuss NADIM ADJUVANT, VATS vs lobectomy, and EA5181/LS SCLC results with leading experts.

🎧 bit.ly/WCLC25Mon

I'm in Barcelona, Now What? — Tips for First-Time WCLC Attendees | IASLC In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WC ...

First time at #WCLC25? 🎉

In this episode of #LungCancerConsidered, @narjustflorezmd.bsky.social & @stephenvliu.bsky.social share 10 tips to help attendees get the most out of the meeting, including how to work in a bit of self-care!

🎧 bit.ly/WCLC1st

In this episode of #LungCancerConsidered in Greek, @drgreeklungcancer.bsky.social hosts Dr. Petros Christopoulos and Dr. Dionysis Papadatos-Pastos to discuss how ALK+ NSCLC is managed in Greece.
🎧 bit.ly/GreekALKVTB

#ALK #NSCLC

LCC in Arabic: Arabic Women’s Voices in Thoracic Oncology | IASLC As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya ...

In this episode of #LungCancerConsidered in Arabic, @naglaakarimmd.bsky.social talks with Dr. Asrar AlAhmadi and Dr. Maya Khalil about the experiences and career paths of Arabic women in thoracic oncology.

🎧 Listen now: bit.ly/ArabWomenTO

Artificial Intelligence and Lung Cancer Research | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu sits down with Dr. Arsela Prelaj to explore what happens when cutting-edge artificial intelligen ...

Can AI transform lung cancer care? In the newest episode of #LungCancerConsidered, @stephenvliu.bsky.social speaks with @arselaprelaj.bsky.social about how artificial intelligence is changing research, diagnostics & treatment in thoracic oncology.

🎧 bit.ly/AIandLCResea...

“Please Don’t Tell My Family”: Stigma and Lung Cancer | IASLC This episode of Lung Cancer Considered takes an in-depth look at lung cancer and its associated stigma – how it differs compared to other cancer types, the ne ...

Why does lung cancer carry more stigma than other cancers, & what can we do to change that? On #LungCancerConsidered, @narjustflorezmd.bsky.social, @drcarterbawa.bsky.social & @hawkeyestudts.bsky.social discuss the stigma & how the medical community can help shift the narrative.

🎧 bit.ly/StigmaLCC

LCC in Japanese: ASCO 2025 Highlights | IASLC As part of IASLC’s Lung Cancer Considered world language series, Dr. Misako Nagasaka hosts this episode in Japanese and reviews important lung cancer data pre ...

The latest episode of #LungCancerConsidered in Japanese explores top #ASCO25 studies, including NEOADAURA, REZILIENT1 & TROPION-Lung02. Dr. Misako Nagasaka hosts with Dr. Yasushi Goto and Dr. Yuko Oya from Japan.

🎧 bit.ly/ASCO25Japanese

Data Dive: Unpacking Datopotomab Deruxtecan and Its Recent FDA Approval | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Jacob Sands to discuss the recent approval of datopotamab deruxtecan for loc ...

📢The FDA just approved datopotamab deruxtecan for advanced EGFR+ NSCLC.

In this week’s #LungCancerConsidered, @narjustflorezmd.bsky.social is joined by Dr. Jacob Sands to break down the approval and its impact on care.
🎧 bit.ly/LCCdatadive
#NSCLC

FDA Approval: Sunvozertinib in EGFR Exon 20 NSCLC | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses EGFR exon 20 insertions and the recently approved targeted therapy for this subset of ...

What does the FDA approval of sunvozertinib mean for patients with EGFR exon 20 insertions? In this week’s #LungCancerConsidered, @stephenvliu.bsky.social talks with Dr. Mariam Alexander and Dr. James Chih-Hsin Yang about the newest EGFR-targeted therapy.

🎧 bit.ly/FDAexon20

LCC in Portuguese: Virtual Tumor Board – EGFR NSCLC | IASLC As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Clarissa Mathias moderates a discussion in Portuguese with Dr. Gu ...

In this episode of #LungCancerConsidered, we're exploring the treatment of EGFR+ NSCLC.

@clarissamathias.bsky.social leads a discussion in Portuguese with Dr. Guilherme Harada and Dr. William N. William.

🎧 Listen: bit.ly/VTBport

#EGFR #NSCLC #Oncology

Virtual Tumor Board: Resectable EGFR NSCLC | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case explor ...

What’s the best approach to resectable EGFR-mutant NSCLC?
In this #LungCancerConsidered Virtual Tumor Board, @stephenvliu.bsky.social leads a discussion with Drs. Chunxia Su & Collin Blakely exploring this complex clinical scenario.

🎧 bit.ly/VTBregfrnsclc

#NSCLC #EGFR

FDA Approval: Taletrectinib and ROS1 NSCLC | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for ...

A new ROS1+ NSCLC therapy is here.
In the latest #LungCancerConsidered, @stephenvliu.bsky.social speaks with Dr. Enriqueta Felip & Dr. Jorge Nieva about the FDA approval of taletrectinib and how it fits into lung cancer care.

🎧 Tune in here: bit.ly/FDATaletrect...

#IASLC #NSCLC

Thymus Talk: Unraveling Thymoma and Thymic Carcinoma | IASLC This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new therapeutic ...

In a new episode of #LungCancerConsidered, @narjustflorezmd.bsky.social talks with Claudia Proto and
@chulkimmd.bsky.social about the evolving treatment options for thymoma and thymic carcinoma.

🎧 Listen now: bit.ly/ThymustalkLCC

#LungCancer #IASLC

IASLC - Thymus Talk: Unraveling Thymoma and Thymic Carcinoma - OncoDaily IASLC - Thymus Talk: Unraveling Thymoma and Thymic Carcinoma / cancer, Chul Kim, Claudia Proto, IASLC, Lung Cancer Considered, Narjust Florez, OncoDaily,

IASLC – Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
@iaslc.bsky.social
@narjustflorezmd.bsky.social

oncodaily.com/blog/iaslc-3...

#Cancer #IASLC #LungCancerConsidered #OncoDaily #Oncology #ThymicCarcinoma #Thymoma

ASCO 2025 Highlights | IASLC This episode of Lung Cancer Considered reviews important lung cancer data presented at ASCO 2025. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephe ...

From HERTHENA-Lung02 to CheckMate 816, the latest #LungCancerConsidered episode breaks down major #ASCO25 lung cancer studies. Join @narjustflorezmd.bsky.social, @stephenvliu.bsky.social, @patrickforde.bsky.social and Dr. Charu Aggarwal for expert insights.

🎧 bit.ly/ASCO25LCC

#NSCLC #SCLC

FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of telisotuzumab vedotin, an antibody-drug conjugate, for NSCL ...

The FDA has approved telisotuzumab vedotin for MET+ NSCLC! On this #LungCancerConsidered episode, @stephenvliu.bsky.social, Dr. Mor Moskovitz and Dr. Jonathan Goldman break down what this means for lung cancer care.

🎧 Listen now: bit.ly/FDATVandMET

#LungCancer #NSCLC

LCC in Korean: Lung Cancer Updates & Future Directions | IASLC As part of IASLC’s Lung Cancer Considered world language series, Dr. Chul Kim discusses EGFR/HER2 mutant NSCLC and SCLC in Korean with Dr. So Yeon Kim and Dr. ...

Explore insights from Korea in this #LungCancerConsidered episode.

‪‪@chulkimmd.bsky.social hosts a Korean-language discussion with Dr. So Yeon Kim and Dr. Se-Hoon Lee on EGFR/HER2 mutant NSCLC and SCLC.

🎧 bit.ly/LCCKor25

#LungCancer #Korea

Virtual Tumor Board: Targeting Residual Disease | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Mara Antonoff, Dr. Shankar Siva, and Dr. David Car ...

In the latest #LungCancerConsidered episode, @stephenvliu.bsky.social moderates a discussion featuring Dr. Mara Antonoff, Dr. Shankar Siva & Dr. David Carbone. They navigate a real-world case & explore current approaches to treatment & clinical decision-making.

🎧 Listen here: bit.ly/VTBresidual

The newest #LungCancerConsidered episode in Mandarin features expert insights on EGFR-mutant #NSCLC. Listen as Dr. Chunxia Su sits down with Drs. Wenfeng Fang & Xiaorong Dong to discuss how EGFR-mutant NSCLC cases are managed in China.

🎧 Tune in: bit.ly/VTBMandarin

#EGFR

Interview with Dr. Bryant Lin: Teaching My Lung Cancer | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Dr. Bryant Lin, Clinical Professor of Medicine at Stanford University and co-founder ...

After years of raising awareness, Dr. Bryant Lin was diagnosed with stage IV EGFR+ lung cancer. In the new #LungCancerConsidered episode, he talks with @stephenvliu.bsky.social about patient experience, treatment, and teaching cancer care.

🎧 Listen: bit.ly/LinTMLC

AACR 2025 Highlights | IASLC In this episode of Lung Cancer Considered, host Dr. Stephen Liu and Dr. Christine Lovly discuss the significant lung cancer findings presented at the American A ...

What should lung cancer clinicians know from #AACR25?
In the latest #LungCancerConsidered episode, @stephenvliu.bsky.social & Dr. Lovly unpack key results from the Beamion LUNG-1, AENEAS, and SignPost studies.

🎧 Listen: bit.ly/AACR25Highli...

What You Should Know About RET-Positive NSCLC: Live from TexasLung25 | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about th ...

On #LungCancerConsidered this week, @narjustflorezmd.bsky.social & Dr. Mihaela Aldea talk about RET-positive NSCLC: diagnostic hurdles, treatment choices & more!

🎧 Tune in: bit.ly/TL25RET

#TexasLung25 #NSCLC

LCC in Turkish: First-Line Therapies in EGFR Mutant NSCLC | IASLC As part of IASLC's ongoing series of podcasts in world languages, Dr. Ece Cali Daylan moderates a discussion in Turkish with Dr. Özden Altundağ and Dr. Saadet ...

We have a new episode of #LungCancerConsidered in Turkish! 🇹🇷 Dr. Ece Cali Daylan leads a case-based discussion on first-line therapies for EGFR-mutant #NSCLC, with insights from FLAURA, FLAURA-2 & MARIPOSA trials.

Listen here: bit.ly/LCCTurkishEGFR

Excuse me, What? Top Recommendations for Effective Patient Communication in Oncology: Live from TexasLung25 | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi and Dr. Mi ...

Live at #TexasLung25, @narjustflorezmd.bsky.social hosts Drs. Eric Singhi & Misty Shields on a new episode of #LungCancerConsidered for a talk on patient education & communication in oncology.

🎧 Listen now: bit.ly/TL25LCC

#TexasLung25 #patientadvocacy #oncology

ELCC 2025: Insights and Review of the Data | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Corey Langer discuss data presented at the recent European Lung Cancer Congress (ELCC ...

On the new episode of #LungCancerConsidered @narjustflorezmd.bsky.social & Dr. Corey Langer discuss major updates from #ELCC25. These updates include MARIPOSA and ORCHARD & SOHO-01 trials, plus strategies to address treatment toxicity.

🎧 Listen here: bit.ly/LCC25ELCC

#ELCC25